Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species
Steven E. Rowland, Patsy Clark, Robert Gordon, Anne K. Mullen, Jocelyne Guay, Lynn Dufresne, Christine Brideau, Bernard Cote, Yves Ducharme, Joseph Mancini, Chi-chung Chan, Laurent Audoly, Daigen XuVolume:
560
Year:
2007
Language:
english
Pages:
9
DOI:
10.1016/j.ejphar.2007.01.008
File:
PDF, 1006 KB
english, 2007